Valdair Ferreira Pinto. Show Affiliations »
Abstract
Mesh： See more » Biological Products/standardsBiosimilar Pharmaceuticals/adverse effectsBiosimilar Pharmaceuticals/pharmacokineticsBiosimilar Pharmaceuticals/standardsClinical Trials as TopicGuidelines as Topic/standardsTherapeutic EquivalencyWorld Health Organization
Substances： See more » Biological ProductsBiosimilar Pharmaceuticals
Year: 2011 PMID： 21755255 DOI： 10.1590/s1516-31802011000300011
Source DB: PubMed Journal: Sao Paulo Med J ISSN： 1516-3180 Impact factor: 1.044